These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 17381079)

  • 21. Development of anti-coxsackievirus agents targeting 3C protease.
    Kim BK; Kim JH; Kim NR; Lee WG; Lee SD; Yun SH; Jeon ES; Kim YC
    Bioorg Med Chem Lett; 2012 Nov; 22(22):6952-6. PubMed ID: 23062551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stable benzotriazole esters as mechanism-based inactivators of the severe acute respiratory syndrome 3CL protease.
    Wu CY; King KY; Kuo CJ; Fang JM; Wu YT; Ho MY; Liao CL; Shie JJ; Liang PH; Wong CH
    Chem Biol; 2006 Mar; 13(3):261-8. PubMed ID: 16638531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sabadinine: a potential non-peptide anti-severe acute-respiratory-syndrome agent identified using structure-aided design.
    Toney JH; Navas-Martín S; Weiss SR; Koeller A
    J Med Chem; 2004 Feb; 47(5):1079-80. PubMed ID: 14971887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diarylheptanoids from Alnus japonica inhibit papain-like protease of severe acute respiratory syndrome coronavirus.
    Park JY; Jeong HJ; Kim JH; Kim YM; Park SJ; Kim D; Park KH; Lee WS; Ryu YB
    Biol Pharm Bull; 2012; 35(11):2036-42. PubMed ID: 22971649
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New 4-phenylcoumarin derivatives as potent 3C protease inhibitors: Design, synthesis, anti-HAV effect and molecular modeling.
    Kassem AF; Batran RZ; Abbas EMH; Elseginy SA; Shaheen MNF; Elmahdy EM
    Eur J Med Chem; 2019 Apr; 168():447-460. PubMed ID: 30844608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 4. Incorporation of P1 lactam moieties as L-glutamine replacements.
    Dragovich PS; Prins TJ; Zhou R; Webber SE; Marakovits JT; Fuhrman SA; Patick AK; Matthews DA; Lee CA; Ford CE; Burke BJ; Rejto PA; Hendrickson TF; Tuntland T; Brown EL; Meador JW; Ferre RA; Harr JE; Kosa MB; Worland ST
    J Med Chem; 1999 Apr; 42(7):1213-24. PubMed ID: 10197965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 2. Peptide structure-activity studies.
    Dragovich PS; Webber SE; Babine RE; Fuhrman SA; Patick AK; Matthews DA; Reich SH; Marakovits JT; Prins TJ; Zhou R; Tikhe J; Littlefield ES; Bleckman TM; Wallace MB; Little TL; Ford CE; Meador JW; Ferre RA; Brown EL; Binford SL; DeLisle DM; Worland ST
    J Med Chem; 1998 Jul; 41(15):2819-34. PubMed ID: 9667971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure-based design of a parallel synthetic array directed toward the discovery of irreversible inhibitors of human rhinovirus 3C protease.
    Johnson TO; Hua Y; Luu HT; Brown EL; Chan F; Chu SS; Dragovich PS; Eastman BW; Ferre RA; Fuhrman SA; Hendrickson TF; Maldonado FC; Matthews DA; Meador JW; Patick AK; Reich SH; Skalitzky DJ; Worland ST; Yang M; Zalman LS
    J Med Chem; 2002 May; 45(10):2016-23. PubMed ID: 11985469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peptidyl diazomethyl ketones inhibit the human rhinovirus 3C protease: effect on virus yield by partial block of P3 polyprotein processing.
    Murray MA; Janc JW; Venkatraman S; Babé LM
    Antivir Chem Chemother; 2001 Sep; 12(5):273-81. PubMed ID: 11900346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization and inhibition of SARS-coronavirus main protease.
    Liang PH
    Curr Top Med Chem; 2006; 6(4):361-76. PubMed ID: 16611148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential Broad Spectrum Inhibitors of the Coronavirus 3CLpro: A Virtual Screening and Structure-Based Drug Design Study.
    Berry M; Fielding BC; Gamieldien J
    Viruses; 2015 Dec; 7(12):6642-60. PubMed ID: 26694449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An episulfide cation (thiiranium ring) trapped in the active site of HAV 3C proteinase inactivated by peptide-based ketone inhibitors.
    Yin J; Cherney MM; Bergmann EM; Zhang J; Huitema C; Pettersson H; Eltis LD; Vederas JC; James MN
    J Mol Biol; 2006 Aug; 361(4):673-86. PubMed ID: 16860823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 1. Michael acceptor structure-activity studies.
    Dragovich PS; Webber SE; Babine RE; Fuhrman SA; Patick AK; Matthews DA; Lee CA; Reich SH; Prins TJ; Marakovits JT; Littlefield ES; Zhou R; Tikhe J; Ford CE; Wallace MB; Meador JW; Ferre RA; Brown EL; Binford SL; Harr JE; DeLisle DM; Worland ST
    J Med Chem; 1998 Jul; 41(15):2806-18. PubMed ID: 9667970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peptidomimetic ethyl propenoate covalent inhibitors of the enterovirus 71 3C protease: a P2-P4 study.
    Ang MJ; Lau QY; Ng FM; Then SW; Poulsen A; Cheong YK; Ngoh ZX; Tan YW; Peng J; Keller TH; Hill J; Chu JJ; Chia CS
    J Enzyme Inhib Med Chem; 2016; 31(2):332-9. PubMed ID: 25792507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and evaluation of peptidyl Michael acceptors that inactivate human rhinovirus 3C protease and inhibit virus replication.
    Kong JS; Venkatraman S; Furness K; Nimkar S; Shepherd TA; Wang QM; Aubé J; Hanzlik RP
    J Med Chem; 1998 Jul; 41(14):2579-87. PubMed ID: 9651162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure-based design and synthesis of macrocyclic human rhinovirus 3C protease inhibitors.
    Namoto K; Sirockin F; Sellner H; Wiesmann C; Villard F; Moreau RJ; Valeur E; Paulding SC; Schleeger S; Schipp K; Loup J; Andrews L; Swale R; Robinson M; Farady CJ
    Bioorg Med Chem Lett; 2018 Mar; 28(5):906-909. PubMed ID: 29433930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of the severe acute respiratory syndrome 3CL protease by peptidomimetic alpha,beta-unsaturated esters.
    Shie JJ; Fang JM; Kuo TH; Kuo CJ; Liang PH; Huang HJ; Wu YT; Jan JT; Cheng YS; Wong CH
    Bioorg Med Chem; 2005 Sep; 13(17):5240-52. PubMed ID: 15994085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New Potent SARS-CoV 3C-Like Protease Inhibitors Derived from Thieno[2,3-d]-pyrimidine Derivatives.
    Abd El-All AS; Atta SM; Roaiah HM; Awad EM; Abdalla MM
    Arch Pharm (Weinheim); 2016 Mar; 349(3):202-10. PubMed ID: 26806115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A systematic approach to the optimization of substrate-based inhibitors of the hepatitis C virus NS3 protease: discovery of potent and specific tripeptide inhibitors.
    Llinàs-Brunet M; Bailey MD; Ghiro E; Gorys V; Halmos T; Poirier M; Rancourt J; Goudreau N
    J Med Chem; 2004 Dec; 47(26):6584-94. PubMed ID: 15588093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Substituted benzamide inhibitors of human rhinovirus 3C protease: structure-based design, synthesis, and biological evaluation.
    Reich SH; Johnson T; Wallace MB; Kephart SE; Fuhrman SA; Worland ST; Matthews DA; Hendrickson TF; Chan F; Meador J; Ferre RA; Brown EL; DeLisle DM; Patick AK; Binford SL; Ford CE
    J Med Chem; 2000 May; 43(9):1670-83. PubMed ID: 10794684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.